238 related articles for article (PubMed ID: 24782604)
1. Adjuvant chemotherapy for gastric cancer: current evidence and future challenges.
Miceli R; Tomasello G; Bregni G; Di Bartolomeo M; Pietrantonio F
World J Gastroenterol; 2014 Apr; 20(16):4516-25. PubMed ID: 24782604
[TBL] [Abstract][Full Text] [Related]
2. CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer.
Slagter AE; Jansen EPM; van Laarhoven HWM; van Sandick JW; van Grieken NCT; Sikorska K; Cats A; Muller-Timmermans P; Hulshof MCCM; Boot H; Los M; Beerepoot LV; Peters FPJ; Hospers GAP; van Etten B; Hartgrink HH; van Berge Henegouwen MI; Nieuwenhuijzen GAP; van Hillegersberg R; van der Peet DL; Grabsch HI; Verheij M
BMC Cancer; 2018 Sep; 18(1):877. PubMed ID: 30200910
[TBL] [Abstract][Full Text] [Related]
3. Perioperative chemotherapy for resectable gastric cancer: MAGIC and beyond.
Choi AH; Kim J; Chao J
World J Gastroenterol; 2015 Jun; 21(24):7343-8. PubMed ID: 26139980
[TBL] [Abstract][Full Text] [Related]
4. What make differences in the outcome of adjuvant treatments for resected gastric cancer?
Nakajima T; Fujii M
World J Gastroenterol; 2014 Sep; 20(33):11567-73. PubMed ID: 25206264
[TBL] [Abstract][Full Text] [Related]
5. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH
Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake?
Reddavid R; Sofia S; Chiaro P; Colli F; Trapani R; Esposito L; Solej M; Degiuli M
World J Gastroenterol; 2018 Jan; 24(2):274-289. PubMed ID: 29375213
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.
Cats A; Jansen EPM; van Grieken NCT; Sikorska K; Lind P; Nordsmark M; Meershoek-Klein Kranenbarg E; Boot H; Trip AK; Swellengrebel HAM; van Laarhoven HWM; Putter H; van Sandick JW; van Berge Henegouwen MI; Hartgrink HH; van Tinteren H; van de Velde CJH; Verheij M;
Lancet Oncol; 2018 May; 19(5):616-628. PubMed ID: 29650363
[TBL] [Abstract][Full Text] [Related]
8. Gastric cancer in the elderly: an overview.
Saif MW; Makrilia N; Zalonis A; Merikas M; Syrigos K
Eur J Surg Oncol; 2010 Aug; 36(8):709-17. PubMed ID: 20542657
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant and neoadjuvant therapy for gastric cancer.
Kelsen DP
Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
[TBL] [Abstract][Full Text] [Related]
10. [Effectiveness of precautionary chemotherapy in gastric cancer].
Rimassa L; Campagnoli E; Biancofiore G
Tumori; 2000; 86(5 Suppl 2):S5-13. PubMed ID: 11195303
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy: survival benefit in gastric cancer.
Das M
Lancet Oncol; 2017 Jun; 18(6):e307. PubMed ID: 28483410
[No Abstract] [Full Text] [Related]
12. Adjuvant therapy for locally advanced gastric cancer.
Aoyama T; Yoshikawa T
Surg Today; 2017 Nov; 47(11):1295-1302. PubMed ID: 28251375
[TBL] [Abstract][Full Text] [Related]
13. Impact of neoadjuvant chemotherapy with PELF-protocoll versus surgery alone in the treatment of advanced gastric carcinoma.
Ruf C; Thomusch O; Goos M; Makowiec F; Illerhaus G; Ruf G
BMC Surg; 2014 Jan; 14():5. PubMed ID: 24461063
[TBL] [Abstract][Full Text] [Related]
14. Medical management of gastric cancer: a 2014 update.
Elimova E; Shiozaki H; Wadhwa R; Sudo K; Chen Q; Estrella JS; Blum MA; Badgwell B; Das P; Song S; Ajani JA
World J Gastroenterol; 2014 Oct; 20(38):13637-47. PubMed ID: 25320502
[TBL] [Abstract][Full Text] [Related]
15. Perioperative chemotherapy for resectable gastroesophageal cancer: a single-center experience.
Molina R; Lamarca A; Martínez-Amores B; Gutiérrez A; Blázquez A; López A; Granell J; Álvarez-Mon M
Eur J Surg Oncol; 2013 Aug; 39(8):814-22. PubMed ID: 23755989
[TBL] [Abstract][Full Text] [Related]
16. Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses.
Park SH; Sohn TS; Lee J; Lim DH; Hong ME; Kim KM; Sohn I; Jung SH; Choi MG; Lee JH; Bae JM; Kim S; Kim ST; Park JO; Park YS; Lim HY; Kang WK
J Clin Oncol; 2015 Oct; 33(28):3130-6. PubMed ID: 25559811
[TBL] [Abstract][Full Text] [Related]
17. A phase II study of adjuvant S-1/cisplatin chemotherapy followed by S-1-based chemoradiotherapy for D2-resected gastric cancer.
Shim HJ; Kim KR; Hwang JE; Bae WK; Ryu SY; Park YK; Nam TK; Chung IJ; Cho SH
Cancer Chemother Pharmacol; 2016 Mar; 77(3):605-12. PubMed ID: 26846507
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant therapy for gastric cancer: current and future directions.
Foo M; Leong T
World J Gastroenterol; 2014 Oct; 20(38):13718-27. PubMed ID: 25320509
[TBL] [Abstract][Full Text] [Related]
19. Towards personalized perioperative treatment for advanced gastric cancer.
Miao RL; Wu AW
World J Gastroenterol; 2014 Sep; 20(33):11586-94. PubMed ID: 25206266
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.
Bang YJ; Kim YW; Yang HK; Chung HC; Park YK; Lee KH; Lee KW; Kim YH; Noh SI; Cho JY; Mok YJ; Kim YH; Ji J; Yeh TS; Button P; Sirzén F; Noh SH;
Lancet; 2012 Jan; 379(9813):315-21. PubMed ID: 22226517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
